Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Five Prime Therapeutics, Inc. ( FPRX ) was a big mover last session, as the company saw its shares rise by roughly 23% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.  This continues the recent uptrend of the company as the stock has now gained almost 67% since Mar 3.

This biotechnology company has seen no estimate revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Five Prime Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

Five Prime Therapeutics has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the industrial goods sector include Alkermes plc ( ALKS ), Alexion Pharmaceuticals, Inc. ( ALXN ) and ANI Pharmaceuticals, Inc. ( ANIP ).  All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC (ALKS): Free Stock Analysis Report

ALEXION PHARMA (ALXN): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

FIVEPRIME THERA (FPRX): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: ALKS , ALXN , ANIP , FPRX

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by